Shattuck Labs, Inc. (STTK) Financial Statements
Industry: Pharmaceutical Preparations
In fiscal 2025, Shattuck Labs reported revenue of $1.0M, down 82.5% from $5.7M the year before. Net income was -$48.8M (a -4880.9% net margin), or -$0.70 per diluted share. Operating margin was -5150.8%. Operating activities generated -$39.9M of cash, leaving -$40.0M of free cash flow. At fiscal year end, Shattuck Labs held $91.0M in total assets against $8.6M in total liabilities, including $54.2M of cash and equivalents.
Open the full interactive Shattuck Labs financials → Quarterly statements, key ratios, valuation history and price charts.
Shattuck Labs Key Stats
| Share Price | $5.49 |
|---|---|
| Market Cap | $712.5M |
| Revenue YoY Growth | -82.5% |
| 52-Week Range | $1.77 – $8.06 |
| Shares Outstanding | 129.8 million (basic, 2026 Q2) |
Shattuck Labs Income Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $9.9M | $30.0M | $652,000 | $1.7M | $5.7M | $1.0M |
| Operating Income | -$36.9M | -$45.3M | -$103.3M | -$92.0M | -$80.6M | -$51.5M |
| Pre-Tax Income | -$36.6M | -$45.0M | -$101.9M | -$87.3M | -$75.4M | -$48.8M |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$36.6M | -$45.0M | -$101.9M | -$87.3M | -$75.4M | -$48.8M |
| Diluted EPS | -$2.36 | -$1.07 | -$2.41 | -$2.05 | -$1.49 | -$0.70 |
Shattuck Labs Quarterly Results
| 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | |
|---|---|---|---|---|
| Revenue | $1.0M | $0 | $0 | $0 |
| Net Income | -$10.1M | -$12.6M | -$14.8M | -$15.2M |
| Diluted EPS | -$0.14 | -$0.18 | -$0.13 | -$0.12 |
Shattuck Labs Balance Sheet
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $157.9M | $92.3M | $47.4M | $125.6M | $57.4M | $54.2M |
| Current Assets | $345.6M | $288.3M | $184.6M | $143.2M | $79.2M | $82.5M |
| Total Assets | $349.0M | $298.6M | $205.3M | $159.6M | $91.0M | $91.0M |
| Current Liabilities | $16.8M | $24.6M | $25.0M | $11.5M | $8.9M | $7.1M |
| Total Liabilities | $39.1M | $26.8M | $29.2M | $14.9M | $11.4M | $8.6M |
| Shareholders' Equity | $309.9M | $271.8M | $176.2M | $144.7M | $79.6M | $82.4M |
Shattuck Labs Cash Flow Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash From Operations | -$33.7M | -$57.1M | -$94.5M | -$81.2M | -$60.5M | -$39.9M |
| Cash From Investing | -$146.3M | -$10.4M | $49.4M | $110.9M | -$8.5M | -$7.9M |
| Cash From Financing | $330.9M | $1.9M | $171,000 | $48.6M | $787,000 | $44.6M |
| Free Cash Flow | -$34.4M | -$65.0M | -$106.1M | -$81.6M | -$60.6M | -$40.0M |
Figures from Shattuck Labs' 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full Shattuck Labs financials page for every line item.
Shattuck Labs Company Profile
| Ticker | STTK |
|---|---|
| Exchange | Nasdaq |
| Industry | Pharmaceutical Preparations |
| Headquarters | Austin, Texas |
| Incorporated in | Delaware |
| Fiscal Year End | December 31 |
| SEC Filer Category | Non-accelerated filer, smaller reporting company |
| SEC CIK | 0001680367 |
Frequently Asked Questions
What was Shattuck Labs' revenue in fiscal 2025?
Shattuck Labs (STTK) reported revenue of $1.0M for fiscal 2025.
What is Shattuck Labs' annual revenue history?
Shattuck Labs' annual revenue by fiscal year: 2020: $9.9M; 2021: $30.0M; 2022: $652,000; 2023: $1.7M; 2024: $5.7M; 2025: $1.0M.
What was Shattuck Labs' net income in fiscal 2025?
Shattuck Labs reported net income of -$48.8M for fiscal 2025.
What was Shattuck Labs' earnings per share (EPS) in fiscal 2025?
Shattuck Labs' diluted EPS was -$0.70 for fiscal 2025 (adjusted for any later stock splits).
How much free cash flow did Shattuck Labs generate in fiscal 2025?
Shattuck Labs generated -$40.0M of free cash flow in fiscal 2025.
What was Shattuck Labs' revenue last quarter?
In its most recent reported quarter (2026 Q2), Shattuck Labs reported revenue of $0.
How many shares of Shattuck Labs are outstanding?
Shattuck Labs reported a weighted average of 129.8 million basic shares outstanding in 2026 Q2.
What is Shattuck Labs' market cap?
Based on its latest closing price, Shattuck Labs (STTK) has a market capitalization of about $712.5M.
When does Shattuck Labs' fiscal year end?
Shattuck Labs' fiscal year end, as registered with the SEC, is December 31.
Where is Shattuck Labs headquartered?
Shattuck Labs lists its business address in Austin, Texas in its SEC filings.